Filing Flows › Maxcyte (MXCT) › Who owns the stock
Who owns Maxcyte (MXCT) stock
117 funds reported Maxcyte (MXCT) shares in their latest 13F filings, worth $98.7M in all. The largest holder is River Global Investors LLP ($13.5M). Last quarter 68 funds added to their stakes and 55 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| River Global Investors LLP | 3,253,192 | $13.5M | increase | 2024-12-31 |
| Capricorn Fund Managers | 8,200,000 | $9.2M | unchanged | 2026-09-30 |
| Vanguard Group | 5,539,260 | $8.6M | decrease | 2025-12-31 |
| Vitruvian Partners LLP | 5,043,356 | $6.2M | unchanged | 2026-06-30 |
| Vanguard Capital Management LLC | 4,031,284 | $5.0M | increase | 2026-06-30 |
| Morgan Stanley | 3,694,049 | $4.5M | increase | 2026-06-30 |
| AXA Investment Managers S.A. | 2,773,554 | $4.4M | base | 2025-09-30 |
| Mudita Advisors LLP | 3,370,689 | $4.1M | unchanged | 2026-06-30 |
| BlackRock | 3,060,960 | $3.8M | decrease | 2026-06-30 |
| BNP Paribas Asset Management Holding S.A. | 2,773,554 | $3.4M | unchanged | 2026-06-30 |
| Cadian Capital Management, LP | 2,201,166 | $2.7M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 1,910,800 | $2.4M | decrease | 2026-06-30 |
| AQR Capital Management LLC | 1,882,776 | $2.3M | increase | 2026-06-30 |
| Peapod Lane Capital LLC | 1,980,392 | $2.2M | decrease | 2026-09-30 |
| Jane Street Group, LLC | 1,563,003 | $1.9M | increase | 2026-06-30 |
Maxcyte's latest quarter
Maxcyte, Q2 2026: revenue $7.3M (-14% year over year), operating margin -140.7%, net loss $8.9M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most MXCT stock?
By the latest 13F filings: River Global Investors LLP ($13.5M); Capricorn Fund Managers ($9.2M); Vanguard Group ($8.6M); Vitruvian Partners LLP ($6.2M); Vanguard Capital Management LLC ($5.0M).
What is the short interest in MXCT?
1,831,817 shares were sold short at the 2026-10-15 settlement, 68.06% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.